Directory
>
Greg Glenn
Greg Glenn
Founder | Novavax
Maryland, Rockville, United States
Greg Glenn
Summary
Greg Glenn is a seasoned executive in the biotechnology sector, currently serving as the President of Research and Development at Novavax, a prominent company in vaccine development. With a strong academic foundation in Biology and Chemistry from Whitman College, he has dedicated over a decade to advancing clinical research and product development in his current role. His expertise encompasses various facets of the industry, including patents, marketing, and initial public offerings (IPOs). Greg's leadership is characterized by a focus on innovation and strategic growth, making him a pivotal figure in the company's mission to combat infectious diseases. He has a track record of driving research initiatives that lead to significant advancements in vaccine technology. Outside of his professional accomplishments, he is passionate about fostering collaboration between research and clinical application, ensuring that scientific breakthroughs translate into real-world solutions.
Greg Glenn
Work Experience
Chief Executive Officer at
Pinion Immunotherapeutics
June 2024 - Present
Greg Glenn
Education
Whitman College, Biology-Chemisty
January 1972 - January 1976
Frequently Asked Questions about Greg Glenn
What is Greg Glenn email address?
Greg Glenn's primary email address is *******@novavax.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Greg Glenn work for?
Greg Glenn is a Founder at Novavax.
Where Greg Glenn graduated from?
Greg Glenn holds a degree in null from Whitman College.
How can I directly contact Greg Glenn?
To contact Greg Glenn directly, you can use the email address *******@novavax.com. Complete contact information is available upon registration with Muraena.
Who is Greg Glenn?
Greg Glenn is a seasoned executive in the biotechnology sector, currently serving as the President of Research and Development at Novavax, a prominent company in vaccine development. With a strong academic foundation in Biology and Chemistry from Whitman College, he has dedicated over a decade to advancing clinical research and product development in his current role. His expertise encompasses various facets of the industry, including patents, marketing, and initial public offerings (IPOs). Greg's leadership is characterized by a focus on innovation and strategic growth, making him a pivotal figure in the company's mission to combat infectious diseases. He has a track record of driving research initiatives that lead to significant advancements in vaccine technology. Outside of his professional accomplishments, he is passionate about fostering collaboration between research and clinical application, ensuring that scientific breakthroughs translate into real-world solutions.
Greg`s contact details
*******@novavax.com
Colleagues
Business Analyst
Associate Director, Health Care Member Services
Professor of Pediatrics and Microbiology
Vice President and Head of Worldwide Regulatory Affairs Vaccine development
PRISM Product Development and Support
Pediatric Resident
Staffing Account Manager
Principal Scientist
Systems Analyst